BioXcel Therapeutics, Inc. - COM (BTAI)

Historical Portfolio Holders from Q1 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
3.1M
Holdings value Q3 2024
$1.89M
Value change Q3 2024
-$7.87M
Grand Portfolio weight change Q3 2024
0%
Number of holders
46
Number of buys Q3 2024
10
Number of sells Q3 2024
-50
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 3.1M $1.89M -$7.87M $0.61 47
2024 Q2 9.73M $12.5M -$1.72M $1.28 70
2024 Q1 9.24M $26.1M -$418K $2.82 70
2023 Q4 9.35M $27.6M -$1.94M $2.95 71
2023 Q3 10.1M $25.7M -$27.9M $2.53 80
2023 Q2 17.6M $117M -$7.23M $6.66 85
2023 Q1 17.4M $325M +$71.3M $18.66 95
2022 Q4 13.4M $289M +$37.8M $21.48 79
2022 Q3 11.9M $140M -$11.7M $11.82 81
2022 Q2 12.7M $167M -$8.49M $13.20 89
2022 Q1 13.1M $274M -$16.3M $20.91 92
2021 Q4 13.9M $283M +$19.2M $20.33 90
2021 Q3 12.8M $388M -$6.41M $30.35 101
2021 Q2 13M $379M +$41.3M $29.06 106
2021 Q1 11M $475M -$56.5M $43.16 113
2020 Q4 12.3M $566M +$16.9M $46.20 114
2020 Q3 11.9M $515M +$153M $43.36 106
2020 Q2 8.12M $431M +$117M $53.01 103
2020 Q1 6M $134M +$39.8M $22.35 70
2019 Q4 4.34M $63.3M +$1.45M $14.61 42
2019 Q3 4.18M $29.4M +$8.12M $7.04 41
2019 Q2 2.93M $32M +$4.61M $10.96 34
2019 Q1 2.51M $24.9M +$932K $9.89 19
2018 Q4 2.42M $9.35M -$3.41M $3.85 11
2018 Q3 3.25M $25M -$3.81M $7.66 17
2018 Q2 3.72M $34.2M -$9.9M $9.20 19
2018 Q1 4.7M $47.9M +$47.9M $10.24 22